stockportfolio.pro
Stocks / RIGL vs TCMD
RIGL vs TCMD
Rigel Pharmaceuticals, Inc. and Tactile Systems Technology, Inc. side by side — fundamentals from SEC filings, refreshed nightly. Sector: Healthcare.
| Rigel Pharmaceuticals, Inc. (RIGL) | Tactile Systems Technology, Inc. (TCMD) | |
|---|---|---|
| Market cap | $0.6B | $0.6B |
| Revenue (latest FY) | $294.28M | $329.52M |
| Net income (latest FY) | $367.02M | $19.09M |
| Revenue growth (5y CAGR) | 22.1% | 12.0% |
| Net margin | 124.7% | 5.8% |
| Return on equity | 93.8% | 8.7% |
| P/E ratio | 1.6 | 29.7 |
| Dividend yield | — | — |
| Profitable years (of last 10) | 2 | 7 |
| Positive free cash flow | — | Yes |
Compare them properly — statement by statement
Open either company interactively: 19 years of income statement, balance sheet and cash flow, ratios, health checks, and Ask — the SEC-grounded research assistant.
Open RIGL — free Open TCMD — freeFrequently asked questions
Which is bigger, RIGL or TCMD?
Rigel Pharmaceuticals, Inc. is larger by market capitalization — $0.6B versus $0.6B.
Which grows faster, RIGL or TCMD?
Over the last five fiscal years, Rigel Pharmaceuticals, Inc. grew revenue faster — 22.1%/yr versus 12.0%/yr, computed from SEC-filed statements.
Where does this data come from?
All figures are computed from official SEC filings (10-K), refreshed nightly. This is a data comparison, not investment advice.